Vanguard Capital Opportunity Inv (VHCOX)

70.40 -0.11  -0.16% Aug 7 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 70.40
Turnover Ratio 6.00%
1 Year Fund Level Flows -1.993B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 4.34% 6.29% 95
3M 18.72% 20.11% 62
6M 0.50% 11.74% 93
YTD 3.03% 17.83% 94
1Y 18.31% 30.29% 84
3Y 11.65% 18.10% 90
5Y 12.37% 14.46% 73
10Y 14.80% 15.17% 59
15Y 11.00% 10.32% 36
20Y 8.64% 6.34% 8
As of Aug. 7, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 3.12% 3.12% 0.00%
Stock 96.88% 96.88% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2020

Region Exposure

Americas 86.12%
North America 86.12%
Latin America 0.00%
Greater Europe 7.84%
United Kingdom 0.88%
Europe Developed 6.94%
Europe Emerging 0.02%
Africa/Middle East 0.00%
Greater Asia 6.04%
Japan 0.67%
Australasia 0.00%
Asia Developed 1.21%
Asia Emerging 4.16%
Market Classification
% Developed Markets 95.82%
% Emerging Markets 4.18%
As of March 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 4.85%
Consumer Cyclical 8.86%
Consumer Defensive 0.05%
Energy 1.36%
Financial Services 7.51%
Healthcare 36.43%
Industrials 11.99%
Real Estate 0.01%
Technology 28.93%
Utilities 0.00%
As of March 31, 2020

Stock Market Capitalization

Giant 35.36%
Large 31.38%
Medium 30.76%
Small 2.41%
Micro 0.09%
As of March 31, 2020

Stock Style Exposure

Large Cap Value 15.79%
Large Cap Blend 18.07%
Large Cap Growth 33.02%
Mid Cap Value 10.40%
Mid Cap Blend 8.33%
Mid Cap Growth 11.89%
Small Cap Value 0.82%
Small Cap Blend 0.51%
Small Cap Growth 1.17%
As of March 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
LLY Eli Lilly and Co 5.27% 152.97 +0.03%
BIIB Biogen Inc 4.74% 300.60 -1.67%
AMGN Amgen Inc 3.69% 238.00 -1.12%
BMRN Biomarin Pharmaceutical Inc 3.26% 118.22 -0.38%
MSFT Microsoft Corp 2.63% 207.27 -2.45%
BABA Alibaba Group Holding Ltd ADR 2.58% 247.78 -1.71%
LUV Southwest Airlines Co 2.44% 34.78 +4.51%
ADBE Adobe Inc 2.40% 441.38 -1.82%
QGEN Qiagen NV 2.06% 46.65 -1.40%
SGEN Seattle Genetics Inc 2.03% 156.75 -2.31%
As of March 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. The fund invests mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. It does not focus on companies of any particular size, however; the advisor may emphasize mid-cap stocks. The fund's investment advisor uses fundamental research to identify stocks that are expected to outperform the market over a three- to five-year time horizon and that are available at attractive prices relative to their fundamental values.
General
Security Type Mutual Fund
Oldest Share Symbol VHCOX
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Growth
Prospectus Objective Growth
Fund Owner Firm Name Vanguard
Benchmark Index
Russell Mid Cap Growth TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alfred Mordecai 20.60 yrs
James Marchetti 5.51 yrs
Joel Fried 22.51 yrs
M. Ansari 12.59 yrs
Theo Kolokotrones 22.51 yrs

Share Classes

Symbol Share Class
VHCAX Inst

Net Fund Flows

1M -182.71M
3M -475.60M
6M -1.107B
YTD -1.245B
1Y -1.993B
3Y -4.498B
5Y -5.766B
10Y -7.431B
As of July 31, 2020

Risk Info

Beta (5Y) 1.081
Historical Sharpe Ratio (10Y) 0.9079
Historical Sortino (All) 0.8506
Daily Value at Risk (VaR) 1% (All) 3.62%
Monthly Value at Risk (VaR) 1% (All) 16.78%

Fundamentals

Dividend Yield TTM (8-7-20) 0.71%
30-Day SEC Yield (8-7-20) 0.40%
7-Day SEC Yield --
Weighted Average PE Ratio 14.28
Weighted Average Price to Sales Ratio 1.513
Weighted Average Price to Book Ratio 2.892
Weighted Median ROE 24.46%
Weighted Median ROA 8.19%
Forecasted Dividend Yield 1.62%
Forecasted PE Ratio 15.93
Forecasted Price to Sales Ratio 1.358
Forecasted Price to Book Ratio 2.754
Number of Holdings 152
As of March 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.15%
Forecasted Book Value Growth 4.13%
Forecasted Cash Flow Growth 8.21%
Forecasted Earnings Growth 11.41%
Forecasted Revenue Growth 7.92%
As of March 31, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 3000.00 USD
Minimum Subsequent Investment 1.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.42%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 8/14/1995
Termination Date
Last Annual Report Date 9/30/2019
Last Prospectus Date 1/31/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.